Latest filing published 09 Sept 2026 for Vaxcyte, Inc., €885k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Grant Pickering across 2 companies, led by Vaxcyte, Inc. and LeonaBio, Inc. The record holds 81 filings, for trades running from 21 December 2020 to 8 September 2026.
On the open market, the record shows 1 purchase worth €21k and 36 sales worth €7.1M. Sales outweigh purchases by €7.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 12 share grants and 30 option exercises. In 2026 alone, the filings show no purchases and 6 sales.
On 9 September 2026 came the latest disclosure, a share grant for €885k in Vaxcyte, Inc. The most recent open-market purchase was published on 31 March 2023, 1,300 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 76 declarations